Effective treatment of diabetes in dogs

Abstract

Diabetes in dogs is a common pathology of metabolic disorders, showing an increasing tendency.Twenty clinical diabete dogs raising in Ninh Kieu district, Can Tho city were treated from January to December, 2015. The history, clinical signs, capillary blood sugar concentration and the result of HbA1c test were basic for diagnosis. The dogs were treated for hyperglycaemia by insulin, under the trade name of Mixtard 30, which was manufactured by Novo Nordisk A.S, Denmark. The starting treatment dose was 0.3UI/kg body weight with twice doses per day in an interval of 8 hours. The effectiveness of treatment was monitored for 12 weeks (88 days).The studied results showed that the prevalence of dogs with good glycemic control was 65 %, the average glycemic control was 25 % and poor glycemic control was 10 %. HbA1c content was also decreased significantly, reaching the recommended threshold (< 7 %).